Login Register

Healthcare

00:10:00
Nick Tulloch, CEO of Voyager Life PLC, on Navigating CBD Regulations and the Power of Digital Marketing | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
Executive Chairman Justyn Peters Discusses Project Progress and Market Challenges | Daniel Justyn Douglas Peters, Chairman, Neurizer Ltd.
00:10:00
Voyager Life PLC Launches UK's First Refillable CBD Products, Backed by Deputy First Minister John Swinney | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
Dr. B. Bhaskar Rao on Women's Health Initiatives at Krishna Institute of Medical Sciences | Dr. B. Bhaskar Rao, CEO, Krishna Institute of Medical Sciences Ltd.
00:10:00
Voyager Life PLC CEO Nick Tulloch Discusses Positive Interim Results and Expansion Plans | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
Voyager Life CEO Nick Tulloch Discusses £1.5M Acquisition of Polish CBD Facility and 2023 Outlook | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
Navigating the CBD Market: Insights from Voyager’s CEO | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
Voyager Life CEO Nick Tulloch Discusses Operations Update and Expansion into International Markets | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
Creating Synergy: Bausch + Lomb's CEO Brent Saunders on Fostering Academia-Industry Partnerships |Brent Saunders , CEO, Bausch + Lomb Corp.
00:10:00
Andreas Gerward of Stayble Therapeutics on Treatment Methods and Anticipated Q4'24 Data | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
Reimagining the Workplace: Brent Saunders on the Permanent Shift to Remote Work |Brent Saunders , CEO, Bausch + Lomb Corp.
00:10:00
Andreas Gerward Represents Stayble Therapeutics at NLSDays, Sharing Developments in Life Science | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
Brent Saunders: The Visionary CEO Behind $300 Billion in Mergers & Acquisitions |Brent Saunders , CEO, Bausch + Lomb Corp.
00:10:00
Andreas Gerward, CEO of Stayble Therapeutics, Shares Expertise on Clinical Trials in Eastern Europe and Industry Challenges | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
A 25-Year Veteran Leading Bausch + Lomb's Next Chapter in Healthcare |Brent Saunders , CEO, Bausch + Lomb Corp.
00:10:00
Jean-Claude Maurel on Medesis Pharma’s Strategy for Controlling Inflammatory Cytokine Storms | Jean-Claude Maurel, CEO, Medesis Pharma SA.

© 2017 - Townhall + Tv